Neocardio Diagnostics Private Limited - Company Profile

It is a healthcare private limited company based in Chennai, Tamil Nadu, India, established in 2017.

2017 Chennai, Tamil Nadu, India Converted to LLP

Last Updated: July 26, 2025

About Neocardio Diagnostics Private Limited

Neocardio Diagnostics Private Limited, a converted to llp private limited company, was established on 26 October 2017 in Chennai, Tamil Nadu, India. Engaging in diagnostic centers & pathology labs within the healthcare sector, it holds CIN: U15100TN2017PTC119254. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.

Formerly known as Ki&A Associates Private Limited. It upholds a compliant status. Past directors included Karthik Anand Reddy, Fragkiskos Samaras, Dimitrios Dellis. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at 3Rd Floor, Jhaver Plaza 1-A, Nungambakkam High Road, Chennai, Tamil Nadu, 600034.

Company Details

CIN/LLPIN
U15100TN2017PTC119254
Registration Number
119254
Incorporation Date
26 October 2017
Authorized Capital
₹2.00 Cr
Paid-Up Capital
₹2.00 Cr
ROC Code
Roc Chennai
Listing Status
Unlisted
Company Status
Converted to LLP

Key Metrics

Authorised Capital ₹ 2.00 Cr as on 26-07-2025
Paid Up Capital ₹ 2.00 Cr as on 26-07-2025
Company Age 8 Year, 3 Months
Last Filing with ROC 31 Mar 2019
Revenue Growth **** % (FY 2019)
Profit Growth **** -92.22% (FY 2019)
Ebitda **** -104.82% (FY 2019)
Net Worth -62.19% (FY 2019)
Total Assets -64.09% (FY 2019)

Comprehensive Company Insights

Explore comprehensive insights into Neocardio Diagnostics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Neocardio Diagnostics Private Limited?

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	21 May 2020	Past
Pramod Abcsdd	Director	21 May 2020	Past
Pramod Abcsdd	Additional Director	29 Sep 2018	Past
Pramod Abcsdd	Director	01 Feb 2020	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Neocardio Diagnostics.

Neocardio Diagnostics Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 92.22% decrease in profit. The company's net worth observed a substantial decline by a decrease of 62.19%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

-64.09%

*******

Profit or Loss

*******

-92.22%

*******

Net Worth

*******

-62.19%

*******

EBITDA

*******

-104.82%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Neocardio Diagnostics?

In 2019, Neocardio Diagnostics had a promoter holding of 51.00% and a public holding of 49.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Neocardio Diagnostics?

Unlock and access historical data on people associated with Neocardio Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Neocardio Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neocardio Diagnostics's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Neocardio Diagnostics

Recent Activity within the Organization

Annual General Meeting

Progress on Neocardio Diagnostics Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was documented.
30 Sep 2019
Balance Sheet

Neocardio Diagnostics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Chennai. was recorded as a recent event.
31 Mar 2019
Company Incorporation

Neocardio Diagnostics Private Limited was registered on 26 Oct 2017 with Roc Chennai & aged 8 years 3 months as per MCA records. was recorded as a recent event.
26 Oct 2017

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Neocardio Diagnostics Private Limited?

The CIN of Neocardio Diagnostics Private Limited is U15100TN2017PTC119254.

Where is Neocardio Diagnostics Private Limited headquartered?

Neocardio Diagnostics Private Limited is headquartered at 3Rd Floor, Jhaver Plaza 1-A, Nungambakkam High Road, Chennai, Tamil Nadu, 600034.

When was Neocardio Diagnostics Private Limited incorporated?

Neocardio Diagnostics Private Limited was incorporated on 26 October 2017.

What is the primary industry of Neocardio Diagnostics Private Limited?

The primary industry of Neocardio Diagnostics Private Limited is Healthcare.

Is Neocardio Diagnostics Private Limited a listed company?

Neocardio Diagnostics Private Limited is unlisted.

What is the capital structure of Neocardio Diagnostics Private Limited?

The authorized capital of Neocardio Diagnostics Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.

What is the compliance status of Neocardio Diagnostics Private Limited?

The compliance status of Neocardio Diagnostics Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available